922
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Economic burden of advanced lung cancer patients treated by gefitinib alone and combined with chemotherapy in two regions of China

ORCID Icon, , , , &
Pages 1424-1431 | Received 18 Aug 2023, Accepted 16 Oct 2023, Published online: 31 Oct 2023

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.